[On drug therapy of phlebopathies of the lower extremities with trihydroxyethylrutoside and trihydroxyethylrutoside associated with adrenochromomonosemicarbazone].
D000323:Adrenochrome / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D004338:Drug Combinations; D005260:Female; D005734:Gangrene / Q000188:drug therapy*; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010689:Phlebitis / Q000188:drug therapy; D012431:Rutin / Q000627:therapeutic use*; D012664:Semicarbazones / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy; D014647:Varicose Ulcer / Q000188:drug therapy; D014648:Varicose Veins / Q000188:drug therapy*; D014652:Vascular Diseases / Q000188:drug therapy*
D004338:Drug Combinations; D012664:Semicarbazones; D012431:Rutin; D000323:Adrenochrome
Sulla terapia farmacologica delle flebopatie degli arti inferiori con triidrossietilrutoside e con triidrossietilrutoside associato ad adrenocromomonosemicarbazone.